Numerous studies have reported an association between DBC1 overexpression and poor prognosis across various cancers, including gastric cancer (11–13), breast cancer (14, 15), soft tissue sarcoma (16) colon cancer (17, 18), ovarian cancer (19) and small cell lung cancer (20, 21). Here, CCAR2 is linked to breast cancer.